BiotechTube

bempedoic acid

Phase 3Completed
0 watching 0 views this week📈 Rising
72
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Hypercholesterolemia

Conditions

Hypercholesterolemia, Atherosclerotic Cardiovascular Disease

Trial Timeline

Feb 3, 2017 → Nov 5, 2019

NCT ID
NCT03067441

About bempedoic acid

bempedoic acid is a phase 3 stage product being developed by Esperion Therapeutics for Hypercholesterolemia. The current trial status is completed. This product is registered under clinical trial identifier NCT03067441. Target conditions include Hypercholesterolemia, Atherosclerotic Cardiovascular Disease.

Hype Score Breakdown

Clinical
27
Activity
18
Company
5
Novelty
9
Community
10

Clinical Trials (3)

NCT IDPhaseStatus
NCT05694260Phase 2Completed
NCT03067441Phase 3Completed
NCT02988115Phase 3Completed

Competing Products

20 competing products in Hypercholesterolemia

See all competitors
ProductCompanyStageHype Score
Evacetrapib + Ezetimibe + Atorvastatin + PlaceboEli LillyPhase 3
77
generic formulation of atorvastatin (Atorva®) + branded formulation of atorvastatin (Lipitor®)YuhanApproved
85
Rosuvastatin+Ezetimibe + RosuvastatinYuhanApproved
85
colesevelam HCl tablets, and simvastatin tablets + simvastatin tablets and colesevelam HCl placeboDaiichi SankyoApproved
85
colesevelam HCl tablets and fenofibrate tablets + fenofibrate tablets and Welchol placebo tablets + fenofibrate tablets and Welchol placebo tabletsDaiichi SankyoApproved
85
colesevelam HCl + placeboDaiichi SankyoApproved
85
Bempedoic acid and/or its fixed-dose combination with ezetimibeDaiichi SankyoPre-clinical
23
colesevelam HCl tablets, and atorvastatin tablets + colesevelam HCl placebo tablets and atorvastatin tabletsDaiichi SankyoApproved
85
Bempedoic acid 180 mg tabletDaiichi SankyoApproved
85
Bempedoic Acid 180Mg/Ezetimibe 10Mg TabDaiichi SankyoPre-clinical
23
Colesevelam Hydrochloride + Ezetimibe + SimvastatinDaiichi SankyoApproved
85
pravastatin tablets and Welchol tablets + pravastatin tablets and Welchol placebo tabletsDaiichi SankyoApproved
85
Bempedoic acid and/or its fixed dose combination with ezetimibeDaiichi SankyoPre-clinical
23
atrovastatinAstellas PharmaPre-clinical
23
Pitavastin 4mg + Atorvastatin 20mg + Rosuvastatin 5mgEli LillyApproved
85
PPAR alpha + atorvastatin + placeboEli LillyPhase 2
52
Evacetrapib + PlaceboEli LillyPhase 3
77
LY3015014 + Placebo + Statin + EzetimibeEli LillyPhase 2
52
SHR-1209 single-site subcutaneous injection + SHR-1209 multiple-site subcutaneous injectionsJiangsu Hengrui MedicinePhase 1
33
SHR-1209Jiangsu Hengrui MedicinePhase 2
52

Other Products from Esperion Therapeutics

Bempedoic Acid / Ezetimibe Oral Tablet + PlaceboApproved
80
Bempedoic Acid 180 MG Oral Tablet + Bempedoic Acid/Ezetimibe 180 MG-10 MG Oral TabletApproved
80
Bempedoic acid + EzetimibePhase 3
72
Bempedoic Acid + Ezetimibe + PlacebosPhase 3
72
Bempedoic acid 180 mg tablet + Matching placebo tabletPhase 3
72